Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_09457 | 18 | 0.37 | Mlig455_030003 | Neo: - Age: - |
Mlig455_030003 {REF} {Length: 1601} {RNA1509_44134} {RNA1310_63608.1} {RNA815_45870} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.185 | 0.819 | 0.99953 | 1.00000 | |
RegionR2 | 2.544 | 0.819 | 0.19672 | 0.55523 | |
RegionR3 | 0.975 | 0.819 | 0.99974 | 1.00000 | |
RegionR4 | 0.93 | 0.819 | 0.99977 | 1.00000 | |
RegionR5 | 3.315 | 0.819 | 0.00942 | 0.05529 | |
RegionR6 | 0.417 | 0.819 | 0.99976 | 1.00000 | |
RegionR7 | -0.841 | 0.819 | 0.99978 | 1.00000 | |
RegionR8 | -3.154 | 0.819 | 0.99960 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.94 | 0.819 | 0.99995 | 1.00000 | |
RegenerationR2 | 1.46 | 0.819 | 0.51364 | 0.87722 | |
RegenerationR3 | 1.039 | 0.819 | 0.14179 | 0.56779 | |
RegenerationR4 | 0.974 | 0.819 | 0.20225 | 0.64842 | |
RegenerationR5 | -1.346 | 0.819 | 0.60115 | 0.91031 | |
RegenerationR6 | 2.29 | 0.819 | 0.13424 | 0.44982 | |
RegenerationBL | -0.159 | 0.819 | 0.99995 | 1.00000 | |
RegenerationTP | 0.193 | 0.819 | 0.99996 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_09457 | 18 | 0.37 | Mlig455_030003 | Neo: - Age: - |
3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_030003 {REF} {Length: 1601} {RNA1509_44134} {RNA1310_63608.1} {RNA815_45870} | |
2. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
2.709 | - | - | 0.865 | 0.870 | 0.974 | - | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
3. | MligTC455_49774 | 201 | 4.18 | Mlig455_028574 | Neo: - Age: - Region-enriched R4: 12.872/0.00005 Regeneration-upregulated R3: 5.313 Regeneration-enriched R3: 5.313 |
2.58 | - | - | 0.803 | 0.808 | 0.969 | - | Mlig455_028574 {REF} {Length: 1498} {Pfam: Lectin C-type domain [PF00059.23, score=35.8]} {RNA1509_20946} {RNA1310_44606} {RNA815_35640} | |
4. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 2.576 | - | - | 0.894 | 0.707 | 0.975 | - | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
5. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
2.422 | - | - | 0.734 | 0.712 | 0.976 | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
6. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
1.965 | - | - | 0.987 | - | 0.978 | - | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
7. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 1.949 | - | - | 0.983 | - | 0.966 | - | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
8. | MligTC455_17663 | 10 | 0.22 | Mlig455_052319 | Neo: - Age: - |
1.948 | - | - | 0.995 | - | 0.953 | - | Mlig455_052319 {REF} {Length: 1808} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.9]} {Smed: dd_Smed_v6_54490_0_1, dd_Smed_v6_54490_0_1, [Score=44.3, Expect=8e-06]} {RNA1509_54447} {RNA1310_38734} {RNA815_28111} | |
9. | MligTC455_49885 | 134 | 2.79 | Mlig455_004237, Mlig455_061677 | Neo: - Age: - |
1.946 | - | - | 0.971 | - | 0.975 | - | Mlig455_004237 {REF} {Length: 439} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_56631} {RNA1310_23778} {RNA815_50068} Mlig455_061677 {REF} {Length: 362} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_56631} {RNA1310_23778} {RNA815_50068} |
|
10. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
1.938 | - | - | 0.980 | - | 0.958 | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
11. | MligTC455_15771 | 15 | 0.31 | Mlig455_013616 | Neo: - Age: - |
1.933 | - | - | 0.985 | - | 0.948 | - | Mlig455_013616 {REF} {Length: 1678} {Pfam: Glycine rich protein [PF12810.9, score=28.8]} {RNA1509_48637} {RNA1310_55197} {RNA815_27869} | |
12. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.933 | - | - | 0.960 | - | 0.973 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
13. | MligTC455_53199 | 76 | 1.58 | Mlig455_035187 | Neo: - Age: Up-Down-Down |
1.928 | - | - | - | 0.962 | 0.966 | - | Mlig455_035187 {REF} {Length: 4248} {Pfam: MyTH4 domain [PF00784.19, score=60.4]} {Smed: dd_Smed_v6_19214_0_1, dd_Smed_v6_19214_0_1, [RH, Score=172, Expect=1e-46]} {RNA1310_70974} {RNA815_46536} | |
14. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
1.926 | - | - | 0.945 | - | 0.981 | - | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
15. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
1.912 | - | - | 0.932 | - | 0.980 | - | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
16. | MligTC455_42427 | 30 | 0.63 | Mlig455_040552, Mlig455_062085 | Neo: - Age: - |
ANGPT1, ANGPTL2 | 1.911 | - | - | 0.922 | - | 0.989 | - | Mlig455_040552 {REF} {Length: 1447} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.5]} {Human: ENSG00000154188, ANGPT1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=3e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=4e-27]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=104, Expect=8e-25]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=105, Expect=3e-25]} {Dmel: FBgn0030163, CG1791, [Score=94.4, Expect=3e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=3e-20]} {RNA1310_118725} Mlig455_062085 {REF} {Length: 1538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.9]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=4e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=5e-27]; ENSG00000154188, ANGPT1, angiopoietin 1, [Score=107, Expect=7e-26]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=105, Expect=2e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=2e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=5e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=107, Expect=7e-26]} {Dmel: FBgn0030163, CG1791, [Score=93.6, Expect=5e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=89.4, Expect=5e-20]} {RNA1310_118725} |
17. | MligTC455_18100 | 17 | 0.36 | Mlig455_069127 | Neo: - Age: - |
PPA1 | 1.91 | - | - | 0.956 | - | 0.954 | - | Mlig455_069127 {REF} {Length: 2015} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1509_39915} {RNA1310_57333.1} {RNA815_22340} |
18. | MligTC455_40617 | 11 | 0.22 | Mlig455_043552 | Neo: - Age: - |
WSCD2 | 1.909 | - | - | 0.934 | - | 0.975 | - | Mlig455_043552 {REF} {Length: 962} {Pfam: WSC domain [PF01822.21, score=54.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.2, Expect=1e-09]} |
19. | MligTC455_09405 | 6 | 0.12 | Mlig455_069593 | Neo: - Age: - |
FCN1 | 1.902 | - | - | 0.915 | - | 0.987 | - | Mlig455_069593 {REF} {Length: 1062} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=116.0]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=111, Expect=5e-28]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000028001, Fga, fibrinogen alpha chain, [Score=100, Expect=4e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=4e-24]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=98.6, Expect=1e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=105, Expect=5e-25]} {Celegans: WBGene00020516, T15B7.1, [Score=62.8, Expect=5e-11]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=44.3, Expect=7e-06]} |
20. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
1.901 | - | - | 0.919 | - | 0.982 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
21. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
1.9 | - | - | 0.937 | - | 0.963 | - | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
22. | MligTC455_10383 | 13 | 0.27 | Mlig455_040199 | Neo: - Age: - |
1.898 | - | - | 0.911 | - | 0.987 | - | Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
23. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 1.898 | - | - | 0.911 | - | 0.987 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
24. | MligTC455_12126 | 26 | 0.55 | Mlig455_040946 | Neo: - Age: - |
1.896 | - | - | 0.926 | - | 0.970 | - | Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956} | |
25. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
1.895 | - | - | 0.934 | - | 0.961 | - | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
26. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 1.895 | - | - | 0.966 | - | 0.929 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
27. | MligTC455_10968 | 7 | 0.14 | Mlig455_015698 | Neo: - Age: - |
HMCN1 | 1.893 | - | - | 0.915 | - | 0.978 | - | Mlig455_015698 {REF} {Length: 1150} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=52.4, Expect=5e-07]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=60.5, Expect=6e-10]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [Score=51.6, Expect=2e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=60.1, Expect=4e-10]} {RNA1310_100476} {RNA815_63742} |
28. | MligTC455_14795 | 8 | 0.16 | Mlig455_001604 | Neo: - Age: - |
NPR1 | 1.893 | - | - | 0.915 | - | 0.978 | - | Mlig455_001604 {REF} {Length: 2245} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=181.5]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=251, Expect=3e-71]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=243, Expect=2e-68]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-70]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=244, Expect=1e-71]} {Dmel: FBgn0010197, Gyc32E, Guanyl cyclase at 32E, [Score=227, Expect=4e-63]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=224, Expect=2e-62]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [Score=225, Expect=1e-62]} {RNA1310_77875} |
29. | MligTC455_19850 | 21 | 0.44 | Mlig455_016817 | Neo: - |
GUCY1B1 | 1.892 | - | - | 0.899 | - | 0.993 | - | Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
30. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.892 | - | - | 0.911 | - | 0.981 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
31. | MligTC455_17633 | 25 | 0.51 | Mlig455_066373 | Neo: - Age: - |
RHBG | 1.891 | - | - | 0.913 | - | 0.978 | - | Mlig455_066373 {REF} {Length: 1855} {Pfam: Ammonium Transporter Family [PF00909.23, score=389.0]} {Human: ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=60.8, Expect=3e-09]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [RH, Score=459, Expect=5e-157]} {Celegans: WBGene00000135, amt-3, Putative ammonium transporter 3, [RH, Score=401, Expect=1e-132]} {RNA1310_75971} {RNA815_45087} |
32. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
1.888 | - | - | 0.907 | - | 0.981 | - | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
33. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 1.887 | - | - | 0.909 | - | 0.978 | - | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
34. | MligTC455_22077 | 58 | 1.2 | Mlig455_041277 | Neo: - Age: - |
1.885 | - | - | 0.925 | - | 0.960 | - | Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833} | |
35. | MligTC455_50838 | 30 | 0.62 | Mlig455_016194 | Neo: - Age: - |
1.883 | - | - | 0.979 | - | 0.904 | - | Mlig455_016194 {REF} {Length: 1629} {RNA1310_89913} {RNA815_62205} | |
36. | MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | 1.881 | - | - | - | 0.902 | 0.979 | - | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
37. | MligTC455_46881 | 15 | 0.32 | Mlig455_061546 | Neo: - Age: Down-Up-Up |
IAH1 | 1.88 | - | - | 0.907 | - | 0.973 | - | Mlig455_061546 {REF} {Length: 1647} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=76.2]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.9]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=139, Expect=6e-40]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=122, Expect=1e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=112, Expect=2e-30]} {RNA1310_108127} {RNA815_31492} |
38. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 1.877 | - | - | 0.905 | - | 0.972 | - | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
39. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
1.877 | - | - | 0.891 | - | 0.986 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
40. | MligTC455_39531 | 19 | 0.4 | Mlig455_057918, Mlig455_057946 | Neo: - Age: - |
1.876 | - | - | 0.912 | - | 0.964 | - | Mlig455_057918 {REF} {Length: 2991} {TRANSSPLICED} {Pfam: Ammonium Transporter Family [PF00909.23, score=377.5]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=172, Expect=3e-47]} {Celegans: WBGene00000133, amt-1, Putative ammonium transporter 1, [RH, Score=436, Expect=1e-148]} {RNA1509_13635} {RNA1310_87070} {RNA815_45884} Mlig455_057946 {REF} {Length: 2075} {Pfam: Ammonium Transporter Family [PF00909.23, score=379.7]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=171, Expect=2e-46]} {Celegans: WBGene00000133, amt-1, Putative ammonium transporter 1, [RH, Score=434, Expect=8e-148]} {RNA1310_87070} {RNA815_45884} |
|
41. | MligTC455_15124 | 25 | 0.53 | Mlig455_017684 | Neo: - Age: - |
IGSF9 | 1.873 | - | - | 0.893 | - | 0.980 | - | Mlig455_017684 {REF} {Length: 3509} {Pfam: Immunoglobulin domain [PF13927.8, score=138.2]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=104.0]; Immunoglobulin domain [PF00047.27, score=66.0]; Immunoglobulin V-set domain [PF07686.19, score=56.4]; Fibronectin type III domain [PF00041.23, score=26.9]; Immunoglobulin domain [PF18452.3, score=22.7]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=22.1]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=19.2]} {Human: ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=137, Expect=2e-32]} {Mouse: ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=128, Expect=2e-29]; ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=124, Expect=3e-28]} {Dmel: FBgn0010473, tutl, turtle, [Score=130, Expect=1e-30]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [Score=94.7, Expect=1e-19]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=120, Expect=2e-27]} {RNA1310_85001} |
42. | MligTC455_45285 | 7 | 0.14 | Mlig455_046883 | Neo: - Age: - |
1.871 | - | - | 0.893 | - | 0.978 | - | Mlig455_046883 {REF} {Length: 2303} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]} {Celegans: WBGene00008885, F16C3.1, [RH, Score=57.0, Expect=2e-08]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=80.5, Expect=3e-16]} {RNA1509_24228} {RNA1310_11273} | |
43. | MligTC455_09730 | 7 | 0.15 | Mlig455_040086 | Neo: - Age: - |
ANGPTL2 | 1.87 | - | - | 0.985 | - | 0.885 | - | Mlig455_040086 {REF} {Length: 1106} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=142.1]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=111, Expect=1e-27]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=110, Expect=2e-27]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=109, Expect=6e-27]; ENSG00000160339, FCN2, ficolin 2, [Score=107, Expect=6e-27]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=110, Expect=2e-28]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=5e-27]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=9e-27]} {Dmel: FBgn0034160, CG5550, [Score=109, Expect=1e-28]} {Celegans: WBGene00020516, T15B7.1, [Score=62.4, Expect=4e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=1e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
44. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
1.868 | - | - | 0.897 | - | 0.971 | - | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
45. | MligTC455_12404 | 10 | 0.2 | Mlig455_059246 | Neo: - Age: - |
1.867 | - | - | 0.889 | - | 0.978 | - | Mlig455_059246 {REF} {Length: 1713} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.7]} {RNA1509_24218} {RNA1310_21248} {RNA815_14520} | |
46. | MligTC455_51198 | 15 | 0.3 | Mlig455_043152 | Neo: - Age: - |
1.863 | - | - | 0.950 | - | 0.913 | - | Mlig455_043152 {REF} {Length: 2583} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.9]} {RNA1310_7738.1} {RNA815_28239} | |
47. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.853 | - | - | 0.885 | - | 0.968 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
48. | MligTC455_16844 | 22 | 0.47 | Mlig455_032383 | Neo: - Age: - |
NPY1R | 1.852 | - | - | 0.871 | - | 0.981 | - | Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955} |
49. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.843 | - | - | 0.869 | - | 0.974 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
50. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
1.841 | - | - | 0.871 | - | 0.970 | - | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
51. | MligTC455_02149 | 10 | 0.21 | Mlig455_070095 | Neo: - Age: - |
1.833 | - | - | 0.864 | - | 0.969 | - | Mlig455_070095 {REF} {Length: 1351} {RNA1509_31500} {RNA1310_687} {RNA815_17285} | |
52. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 1.827 | - | - | 0.862 | - | 0.965 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
53. | MligTC455_12673 | 10 | 0.2 | Mlig455_003447 | Neo: - Age: - |
1.825 | - | - | 0.872 | - | 0.953 | - | Mlig455_003447 {REF} {Length: 1947} {RNA1509_51609} {RNA1310_3461} {RNA815_16498} | |
54. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
1.823 | - | - | 0.844 | - | 0.979 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
55. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 1.823 | - | - | 0.844 | - | 0.979 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
56. | MligTC455_21790 | 12 | 0.25 | Mlig455_000267 | Neo: - Age: - |
1.821 | - | - | 0.992 | - | 0.829 | - | Mlig455_000267 {REF} {Length: 986} {Dmel: FBgn0003374, Sgs4, Salivary gland secretion 4, [Score=50.1, Expect=9e-07]} {RNA1310_50649.1} | |
57. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
1.82 | - | - | 0.860 | - | 0.960 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
58. | MligTC455_21227 | 18 | 0.37 | Mlig455_018373 | Neo: - Age: - |
RGS6 | 1.814 | - | - | 0.829 | - | 0.985 | - | Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067} |
59. | MligTC455_23875 | 10 | 0.2 | Mlig455_047531 | Neo: - Age: - |
1.813 | - | - | 0.985 | - | 0.828 | - | Mlig455_047531 {REF} {Length: 2692} {Pfam: Otopetrin [PF03189.15, score=34.6]} {RNA1509_19550} {RNA1310_33220} {RNA815_53207} | |
60. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
1.813 | - | - | 0.839 | - | 0.974 | - | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
61. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
1.813 | - | - | 0.856 | - | 0.957 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
62. | MligTC455_30130 | 62 | 1.29 | Mlig455_040669, Mlig455_068784, Mlig455_068802 | Neo: Irradiation Age: Up-Down-Down |
1.812 | - | - | - | 0.860 | 0.952 | - | Mlig455_040669 {REF} {Length: 3166} {TRANSSPLICED} {RNA1509_20007} {RNA1310_780.1} {RNA815_353.1} Mlig455_068784 {REF} {Length: 3176} {TRANSSPLICED} {RNA1509_20007} {RNA1310_780.1, RNA1509_20007} {RNA1509_20007, RNA815_353.1} Mlig455_068802 {REF} {Length: 3206} {TRANSSPLICED} {RNA1509_20007} {RNA1310_780.1} {RNA815_353.1} |
|
63. | MligTC455_14036 | 33 | 0.69 | Mlig455_059133 | Neo: - Age: - Region-enriched R2: 6.942/0.00135 |
GRIK2 | 1.811 | - | - | 0.836 | - | 0.975 | - | Mlig455_059133 {REF} {Length: 360} {TRANSSPLICED} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.4]; Receptor family ligand binding region [PF01094.30, score=55.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=50.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=31.2]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.6]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=167, Expect=5e-42]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=166, Expect=8e-42]} {Dmel: FBgn0038837, CG3822, [Score=171, Expect=1e-43]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=129, Expect=1e-30]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=273, Expect=6e-84]} |
64. | MligTC455_44766 | 87 | 1.81 | Mlig455_054070 | Neo: - Age: - Region-enriched R2: 8.262/0.00000 |
1.808 | - | - | - | 0.835 | 0.973 | - | Mlig455_054070 {REF} {Length: 1746} {RNA1310_24217} {RNA815_39411} | |
65. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
1.804 | - | - | 0.831 | - | 0.973 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
66. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 1.802 | - | - | 0.844 | - | 0.958 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
67. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 1.797 | - | - | 0.816 | - | 0.981 | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
68. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
1.794 | - | - | 0.825 | - | 0.969 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
69. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
1.793 | - | - | 0.815 | - | 0.978 | - | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
70. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 1.783 | - | - | 0.829 | - | 0.954 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
71. | MligTC455_22428 | 96 | 2.01 | Mlig455_011005 | Neo: - Age: - |
1.783 | - | - | 0.832 | - | 0.951 | - | Mlig455_011005 {REF} {Length: 3873} {Pfam: WS/DGAT C-terminal domain [PF06974.15, score=54.7]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=22.2]; Telomere-associated protein TERB2 [PF15101.8, score=20.0]; ZIP Zinc transporter [PF02535.24, score=18.7]; Ureide permease [PF07168.13, score=17.4]} {Smed: dd_Smed_v6_7004_0_1, dd_Smed_v6_7004_0_1, [Score=151, Expect=2e-37]} {RNA1310_98904} | |
72. | MligTC455_13094 | 121 | 2.52 | Mlig455_005442, Mlig455_005513 | Neo: - Age: Up-Up-Down |
1.782 | - | - | - | 0.806 | 0.976 | - | Mlig455_005442 {REF} {Length: 3816} {Smed: dd_Smed_v6_15433_0_1, dd_Smed_v6_15433_0_1, [Score=141, Expect=1e-34]} {RNA1509_41201} {RNA1310_51044} {RNA815_32534} Mlig455_005513 {REF} {Length: 685} {NoTransDecoderORF} {RNA1310_56412} {RNA815_32534} |
|
73. | MligTC455_36698 | 41 | 0.85 | Mlig455_020379, Mlig455_020438 | Neo: - Age: - Region-enriched R4: 4.050/0.03458 |
1.781 | - | - | 0.825 | - | 0.956 | - | Mlig455_020379 {REF} {Length: 1748} {Celegans: WBGene00007723, C25F9.2, [Score=77.8, Expect=7e-17]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} Mlig455_020438 {REF} {Length: 2872} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=53.1]} {Celegans: WBGene00007723, C25F9.2, [Score=206, Expect=7e-57]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} |
|
74. | MligTC455_26411 | 55 | 1.14 | Mlig455_024911 | Neo: - Age: - |
1.777 | - | - | - | 0.807 | 0.970 | - | Mlig455_024911 {REF} {Length: 2411} {Pfam: SH3 domain [PF00018.30, score=28.9]; Variant SH3 domain [PF14604.8, score=22.2]; Variant SH3 domain [PF07653.19, score=22.1]} {Smed: dd_Smed_v6_8729_0_1, dd_Smed_v6_8729_0_1, [RH, Score=60.1, Expect=5e-10]} {RNA1310_32104} {RNA815_32970} | |
75. | MligTC455_47913 | 139 | 2.89 | Mlig455_025678 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.279/0.00526 |
1.776 | - | - | 0.782 | - | 0.994 | - | Mlig455_025678 {REF} {Length: 634} {RNA1310_78201} {RNA815_41088} | |
76. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.769 | - | - | 0.785 | - | 0.984 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
77. | MligTC455_16526 | 125 | 2.61 | Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760 | Neo: - Age: Up-Down-Down |
GABRG3 | 1.765 | - | - | 0.802 | - | 0.963 | - | Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627} Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065} Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627} Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627} |
78. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.764 | - | - | 0.798 | - | 0.966 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
79. | MligTC455_46699 | 33 | 0.69 | Mlig455_037050 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.785 Region-enriched R4: 3.253/0.03515 |
1.761 | - | - | 0.789 | - | 0.972 | - | Mlig455_037050 {REF} {Length: 1266} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=36.8]; NOPS (NUC059) domain [PF08075.13, score=32.2]; YtkA-like [PF13115.8, score=19.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} | |
80. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.756 | - | - | 0.780 | - | 0.976 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
81. | MligTC455_19049 | 17 | 0.34 | Mlig455_049572 | Neo: - Age: - Region-enriched R2: 8.023/0.01333 |
1.756 | - | - | 0.778 | - | 0.978 | - | Mlig455_049572 {REF} {Length: 1581} {Pfam: Spt20 family [PF12090.10, score=18.3]} | |
82. | MligTC455_38065 | 47 | 0.98 | Mlig455_054213 | Neo: - Age: - |
KREMEN2 | 1.754 | - | - | - | 0.767 | 0.987 | - | Mlig455_054213 {REF} {Length: 924} {Pfam: WSC domain [PF01822.21, score=68.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=1e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.0, Expect=1e-07]} {RNA1509_53783} {RNA1310_43773} {RNA815_23638} |
83. | MligTC455_14873 | 15 | 0.31 | Mlig455_021074 | Neo: - Age: - |
1.751 | - | - | 0.773 | - | 0.978 | - | Mlig455_021074 {REF} {Length: 1075} {Pfam: WSC domain [PF01822.21, score=52.6]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=46.6, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=2e-07]} {RNA1310_33352.1} {RNA815_14158.1} | |
84. | MligTC455_40075 | 72 | 1.5 | Mlig455_003636, Mlig455_003841 | Neo: - Age: - |
1.747 | - | - | 0.783 | - | 0.964 | - | Mlig455_003636 {REF} {Length: 1017} {Pfam: PAN domain [PF00024.28, score=20.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=69.7, Expect=2e-14]} {RNA1310_45613} {RNA815_17816.1} Mlig455_003841 {REF} {Length: 978} {TRANSSPLICED} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=70.5, Expect=1e-14]} {RNA1310_45613} {RNA815_17816.1} |
|
85. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 1.735 | - | - | 0.766 | - | 0.969 | - | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
86. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
1.735 | - | - | 0.761 | - | 0.974 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
87. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 1.732 | - | - | 0.754 | - | 0.978 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
88. | MligTC455_14675 | 24 | 0.5 | Mlig455_009944 | Neo: - Age: logFC(26M/2M)=-0.658 |
KCNIP2 | 1.731 | - | - | - | 0.753 | 0.978 | - | Mlig455_009944 {REF} {Length: 1579} {Pfam: EF-hand domain pair [PF13499.8, score=20.2]; EF hand [PF00036.34, score=18.7]} {Human: ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=159, Expect=3e-47]; ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=158, Expect=9e-47]; ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=158, Expect=2e-46]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=156, Expect=6e-46]} {Mouse: ENSMUSG00000025221, Kcnip2, Kv channel-interacting protein 2, [Score=160, Expect=1e-47]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=158, Expect=2e-46]; ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=157, Expect=2e-46]; ENSMUSG00000079056, Kcnip3, Kv channel interacting protein 3, calsenilin, [Score=153, Expect=6e-45]} {Dmel: FBgn0265595, CG44422, [Score=139, Expect=1e-37]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=112, Expect=7e-30]} {Smed: dd_Smed_v6_9434_0_1, dd_Smed_v6_9434_0_1, [Score=127, Expect=1e-35]} {RNA1310_70865} {RNA815_28132} |
89. | MligTC455_44159 | 80 | 1.67 | Mlig455_019040, Mlig455_055663 | Neo: - Age: Down-Up-Up |
ADRB1, GALR3 | 1.728 | - | - | - | 0.752 | 0.976 | - | Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615} Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615} |
90. | MligTC455_14043 | 12 | 0.26 | Mlig455_016776 | Neo: - Age: - |
ANKRD63 | 1.727 | - | - | - | 0.750 | 0.977 | - | Mlig455_016776 {REF} {Length: 1715} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=122.1]; Ankyrin repeats (many copies) [PF13637.8, score=70.6]; Ankyrin repeats (many copies) [PF13857.8, score=54.8]; Ankyrin repeat [PF00023.32, score=50.2]; Ankyrin repeat [PF13606.8, score=43.7]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=130, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=131, Expect=9e-34]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=66.2, Expect=3e-11]} {Celegans: WBGene00012124, T28D6.4, [Score=62.8, Expect=3e-10]} {Smed: dd_Smed_v6_11187_0_3, dd_Smed_v6_11187_0_3, [Score=56.6, Expect=2e-08]} {RNA815_38023} |
91. | MligTC455_49492 | 10 | 0.21 | Mlig455_054890 | Neo: - Age: - |
1.726 | - | - | 0.748 | - | 0.978 | - | Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
92. | MligTC455_53838 | 10 | 0.21 | Mlig455_008156 | Neo: - Age: - |
1.725 | - | - | 0.747 | - | 0.978 | - | Mlig455_008156 {REF} {Length: 2378} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=7e-08]} {RNA1310_37888} {RNA815_29107} | |
93. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.721 | - | - | 0.740 | - | 0.981 | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
94. | MligTC455_43664 | 35 | 0.73 | Mlig455_039606 | Neo: - Age: - Region-enriched R4: 6.555/0.01908 |
KY | 1.716 | - | - | - | 0.729 | 0.987 | - | Mlig455_039606 {REF} {Length: 4549} {Pfam: WD domain, G-beta repeat [PF00400.34, score=37.6]} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=113, Expect=4e-25]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=112, Expect=7e-25]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=147, Expect=8e-36]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=142, Expect=1e-35]} {Smed: dd_Smed_v6_8615_0_1, dd_Smed_v6_8615_0_1, [Score=293, Expect=7e-90]} {RNA1509_7582} {RNA1310_2203} {RNA815_6135} |
95. | MligTC455_50123 | 29 | 0.61 | Mlig455_063710 | Neo: - Age: - Region-enriched R4: 5.673/0.02044 |
1.713 | - | - | 0.735 | - | 0.978 | - | Mlig455_063710 {REF} {Length: 1119} | |
96. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 1.708 | - | - | 0.730 | - | 0.978 | - | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
97. | MligTC455_16438 | 37 | 0.77 | Mlig455_062255 | Neo: - Age: - |
STUM | 1.706 | - | - | - | 0.732 | 0.974 | - | Mlig455_062255 {REF} {Length: 2394} {Pfam: Ectodermal ciliogenesis protein [PF15795.7, score=81.0]} {Human: ENSG00000203685, STUM, stum, mechanosensory transduction mediator homolog, [RH, Score=51.2, Expect=7e-08]} {Mouse: ENSMUSG00000053963, Stum, mechanosensory transduction mediator, [RH, Score=50.4, Expect=1e-07]} {Dmel: FBgn0050263, stum, stumble, [Score=50.8, Expect=4e-07]} {RNA1310_24095} {RNA815_31266} |
98. | MligTC455_51386 | 763 | 15.89 | Mlig455_041336, Mlig455_056222 | Neo: - Age: - Region-enriched R2: 3.643/0.00016 |
HPGDS | 1.706 | - | - | 0.733 | - | 0.973 | - | Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} |
99. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.7 | - | - | 0.716 | - | 0.984 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
100. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
1.698 | - | - | - | 0.723 | 0.975 | - | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} |